Navigation Links
Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Date:12/7/2012

nvolve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2011 and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
3. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
5. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
6. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
7. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
8. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
9. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
10. Cadence Pharmaceuticals to Host Analyst and Investor Day
11. Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  Victoria Vein & Surgery Clinic is ... Astanza Duality laser in Victoria, Texas . ... well as advanced laser treatments for a variety of medical ... industry to provide more services for their patients. Since adding ... Victoria residents get rid of their ...
(Date:3/27/2015)... 27, 2015 A new report from Kalorama Information ... – Chile , Colombia ... targets for IVD firms.  The healthcare research firm said that ... strategies for the Latin American continent with a population of ... supply operations. However, the country,s regional economic clout does not ...
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... , SAN DIEGO, Dec. 21 ... their highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor, ... The first trial in human subjects, NBI-98854-0801, was a ... in Canada under an approved Clinical Trial Application (CTA) ...
... , CARLSBAD, Calif., Dec. 21 Isis Pharmaceuticals, Inc. ... a $10 million payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: ... OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 ... that has completed a successful Phase 2 program in patients ...
Cached Medicine Technology:Neurocrine Advances VMAT2 Inhibitor Program 2Neurocrine Advances VMAT2 Inhibitor Program 3Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3
(Date:3/29/2015)... 2015 The federal court overseeing ... pending in the U.S. District Court, Northern District ... Management Conference for April 21st at 1:30 p.m. ... the progress of product liability claims filed on ... strokes and other cardiovascular complications due to their ...
(Date:3/29/2015)... 2015 “Health is an endo thing, ... learn more about the cannabinoid system … we learn ... Publius’ Go Endo-Cannabinoid Update ~ new on the ... celebrated. Publius, of The Cannabis Papers: A citizen’s guide ... Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids in ...
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... hip injuries is a growing field in orthopaedic medicine. ... with labral tear to confirm the pain etiology, research ... Medicine’s ( AOSSM ) Specialty Day suggests that pain ... outcomes following arthroscopic hip surgery. , “Our study ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... CHAPEL HILL, N.C., April 18 Sales leaders ... services offered by,Best Practices, LLC and in particular ... the Best Practice Database., (http://www.BestPracticeDatabase.com ) Although documents ... many sales leaders have come to find,outstanding value ...
... WASHINGTON, April 18 The following is being,issued ... and Coalition of Full Service Community Hospitals:, ... and the,conflict of interest it creates between a ... fact, over the last year, the House of,Representatives ...
... LeMaitre,Vascular, Inc. (Nasdaq: LMAT ) announced today ... on April 30, 2008, after the close of the,market. ... be hosted,the same day at 5:00 PM ET. The ... participants may listen to the live webcast at, http://www.lemaitre.com/investor, ...
... much as drug treatments , , FRIDAY, April 18 (HealthDay ... in patients with terminal cancer, according to Japanese researchers ... a total of 517 patients with incurable cancer and ... for these patients was supportive expressive group therapy, in ...
... Masimo CEO and CFO to begin after markets ... close at 2:00 p.m. PT (5:00 p.m. ET), ... the inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced it,will ... after the market closes on Tuesday, April 29, 2008., A ...
... Benefit Sharp Rehabilitation Services -, SAN DIEGO, ... will hold its second annual charity event, a ... in Point Loma on June 20th and,21st. More ... throughout California are,expected to participate. This year, representatives ...
Cached Medicine News:Health News:Sales Executives Finding Value in Best Practice Database 2Health News:Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities 2Health News:Talk Therapy Proves Effective for Terminal Cancer Patients 2Health News:Masimo to Report First Quarter 2008 Financial Results on April 29, 2008 2
... is especially designed for the atraumatic removal ... sleek design of this probe minimizes the ... Due to its 24K gold plating, the ... foreign body incarceration. The magnetic probe is ...
... flexible continuous monitoring, the M3 and M4 ... and neonatal patient care. M Series monitors ... includes a basic set of non-invasive parameters ... Optional Multi-Measurement Server extensions offer Mainstream or ...
... the patients side and in transit., ... measurements in a compact package to match ... care, lower acuity environments, and patient transfer., ... patient monitoring, the IntelliVue MP20 Junior has ...
... High-performance monitoring for flexible care settings., ... monitors combine portability and measurement flexibility ... needs of intermediate care environmentsat the ... strong heritage in patient monitoring, IntelliVue ...
Medicine Products: